Temporal Trends in Clinical Characteristics and In-hospital Mortality Among Patients with COVID-19 in Japan for Waves 1, 2, and 3: A Retrospective Cohort Study
Overview
Microbiology
Pharmacology
Affiliations
Introduction: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3.
Methods: A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included.
Results: A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17-4.07%; relative risk reduction = 23-59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98-11.68%; relative risk reduction = 22-60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66-4.05%; relative risk reduction = 24-50%).
Conclusions: A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients.
Schilling M, Portela M, de Albuquerque M, Martins M BMC Health Serv Res. 2024; 24(1):1125.
PMID: 39334045 PMC: 11428977. DOI: 10.1186/s12913-024-11496-w.
Portoles J, Lopez-Sanchez P, Martin-Rodriguez L, Serrano-Salazar M, Valdenebro-Recio M, Ramos A Clin Kidney J. 2023; 16(2):374-383.
PMID: 36751624 PMC: 9620382. DOI: 10.1093/ckj/sfac239.
Konig S, Hohenstein S, Pellissier V, Leiner J, Hindricks G, Nachtigall I Front Public Health. 2022; 10:1028062.
PMID: 36420010 PMC: 9678052. DOI: 10.3389/fpubh.2022.1028062.